Researchers developed HFIP carbamate compounds that inhibited the endocannabinoid-degrading enzyme MAGL with excellent potency and no detectable cross-reactivity with FAAH, improving on existing research tools.
Read this if you follow endocannabinoid system pharmacology and research tool development.
No detectable cross-reactivity with FAAH
What the researchers found
The existing MAGL inhibitor JZL184, while useful for research, had low-level cross-reactivity with FAAH and peripheral carboxylesterases, which complicated interpretation of some experiments. The researchers developed a new class of O-hexafluoroisopropyl (HFIP) carbamate compounds.
These new inhibitors blocked MAGL in vitro and in vivo with excellent potency and greatly improved selectivity. Crucially, they showed no detectable cross-reactivity with FAAH, the enzyme that degrades the other major endocannabinoid anandamide.
This selectivity mattered because it allowed researchers to study the effects of elevating 2-AG specifically, without simultaneously affecting anandamide levels.
Why it matters
Better research tools lead to better science. By cleanly separating MAGL from FAAH inhibition, these compounds allowed researchers to ask more precise questions about the distinct roles of 2-AG and anandamide in the endocannabinoid system.
The numbers in context
HFIP carbamates showed excellent potency and no detectable FAAH cross-reactivity, compared to JZL184 which had low-level cross-reactivity with FAAH and carboxylesterases.
How the study worked
Medicinal chemistry study designing and synthesizing HFIP carbamate compounds. Tested selectivity against MAGL, FAAH, and other serine hydrolases using activity-based protein profiling. Validated in vivo activity in mice.
What this study cannot tell us
Tool compound development study. These compounds were designed for research, not clinical use. In vivo validation was limited to mice. Long-term safety and pharmacokinetic profiles were not fully characterized.
How to read the evidence
Medicinal chemistry and pharmacology study. Technically rigorous but focused on tool compound development rather than clinical application.
When this study was published
Published in 2012. These compounds and their derivatives have become important tools in endocannabinoid research.
The bigger picture
Endocannabinoid research depends on selective pharmacological tools. Each improvement in selectivity allows researchers to better distinguish between the functions of different endocannabinoids, which matters for developing targeted therapies.
Questions still open
- Could these more selective MAGL inhibitors reveal biological functions that were obscured by less selective tools? Would highly selective MAGL inhibition be safer or more effective than dual MAGL/FAAH inhibition for therapeutic applications?
Common questions
What is MAGL and why does it matter?
Why does selectivity matter?
Read the original research
Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates.
Chemistry & biology, 19(5), 579-88
Citation
Chang, Jae Won; Niphakis, Micah J; Lum, Kenneth M; Cognetta, Armand B; Wang, Chu; Matthews, Megan L; Niessen, Sherry; Buczynski, Matthew W; Parsons, Loren H; Cravatt, Benjamin F. (2012). Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates.. Chemistry & biology, 19(5), 579-88. https://doi.org/10.1016/j.chembiol.2012.03.009
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)
- THC and Antibiotics: Is It Safe to Use Cannabis While on Antibiotics
- THC and Caffeine: The Most Common Drug Combo on Earth
- THC and Diabetes Medication: Blood Sugar Interactions